CGTX icon

Cognition Therapeutics
CGTX

Overview Fund Activity

27 hedge funds and large institutions have $4.59M invested in Cognition Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
27
Holders Change
+7
Holders Change %
+35%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WVP
1
Worth Venture Partners
New Jersey
$473K
2
KAS
2
Kestra Advisory Services
Texas
$656K
3
BCM
3
Bridgeway Capital Management
Texas
$206K
4
FWM
4
Frontier Wealth Management
Missouri
$152K
5
DI
5
Diligent Investors
California
$84K

Top Sellers

1
PM
1
Prosight Management
Texas
$660K
2
ACM
2
AIGH Capital Management
Maryland
$0
3
Two Sigma Investments
3
Two Sigma Investments
New York
$116K
4
Millennium Management
4
Millennium Management
New York
$39K
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$77K
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
$1K 434 +434 New
ACM
27
AIGH Capital Management
Maryland
– – -25,496 Closed
Renaissance Technologies
28
Renaissance Technologies
New York
– – -11,764 Closed
BCA
29
Bray Capital Advisors
Florida
– – -250 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
– – -100 Closed
Wells Fargo
31
Wells Fargo
California
$0 24 – –
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
1
2